# Amgen and DaVita enter into new sourcing and supply agreement

Amgen entered into a six-year Sourcing and Supply Agreement with DaVita Inc. to supply EPOGEN and Aranesp for dialysis services in the United States and Puerto Rico, covering at least 90% of DaVita's annual requirements.

- Type: Contract
- Announced: 2017-01-01
- Where: United States
- Status: completed
- Products: EPOGEN (epoetin alfa), Aranesp (darbepoetin alfa)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Amgen](https://endata.com/companies/21121.md) (supplier)
- [DaVita](https://endata.com/companies/21122.md) (customer)

## Sources

- [amgen.com](https://www.amgen.com/newsroom/press-releases/2017/01/amgen-and-davita-enter-into-new-sourcing-and-supply-agreement), 2017-01-01: "Amgen (NASDAQ:AMGN) today announced it has entered into a six-year Sourcing and Supply Agreement with DaVita Inc."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.